RecruitingNCT06436482

Research of Endobronchial Optical Coherence Tomography in Pre-COPD

Research of Endobronchial Optical Coherence Tomography in Pre-stage of Chronic Obstructive Pulmonary Disease


Sponsor

Sichuan Provincial People's Hospital

Enrollment

80 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The pre-stage of Chronic Obstructive Pulmonary Disease (Pre-COPD) is challenging to diagnose. However, identifying Pre-COPD is a crucial step in the prevention and management of COPD. Endobronchial optical coherence tomography showed the value of diagnosis in Pre-COPD and COPD in previous researchs.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study uses a camera technology called Optical Coherence Tomography (OCT) — similar to an ultrasound but using light — inserted through a breathing tube into the airways to look at early structural changes in the lungs. Researchers want to find signs of pre-COPD (early-stage lung damage before major symptoms appear). **You may be eligible if...** - You are a non-smoker with normal lung function - A CT scan found a small lung nodule, but you have no other lung diseases **You may NOT be eligible if...** - You have any condition that makes a bronchoscopy (a tube inserted into your airway) unsafe - You are already enrolled in another clinical study - You cannot cooperate with the examination or follow-up visits - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOptical Coherence Tomography

Placing the probe of OCT in RB10c through the working channel of bronchoscope for real time dynamic scanning and collecting OCT parameters from participants in different groups.


Locations(1)

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06436482


Related Trials